Literature DB >> 28786804

Social capital and adverse treatment outcomes of tuberculosis: a case-control study.

P R Deshmukh1, A Mundra1, A Dawale2.   

Abstract

SETTINGS: 'Social capital' refers to social norms, relationships, networks and values that affect the functioning and development of society. Social capital influences health positively, but its role in the treatment outcomes of tuberculosis (TB) is not known.
OBJECTIVES: To study the role of social capital in determining adverse TB treatment outcomes.
DESIGN: Of 516 patients registered under the Revised National Tuberculosis Control Programme in 2014 in Wardha Tuberculosis Unit, Wardha, India, we included 88 patients with adverse treatment outcomes as cases and 187 controls from among those without adverse outcomes. Multiple logistic regression was used to compare standardised Z-scores.
RESULTS: A greater proportion of controls than cases belonged to higher quartiles of social capital and its domains than cases, and the mean standardised Z-score was also consistently higher among controls than cases. Respectively 47% and 15% of cases and controls were in the poorest quartile of social capital, whereas respectively 10% and 33% of cases and controls were in the richest quartile. Each unit increase in Z-score of overall social capital reduced the odds of adverse treatment outcomes by 63.1%.
CONCLUSION: Appropriate interventions for building social capital for TB patients and linking them with the programme would improve programme performance.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28786804     DOI: 10.5588/ijtld.16.0919

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  1 in total

1.  What Constitutes Health Care Seeking Pathway of TB Patients: A Qualitative Study in Rural Bangladesh.

Authors:  Tanvir Shatil; Nusrat Khan; Fakir Md Yunus; Anita Sharif Chowdhury; Saifur Reza; Shayla Islam; Akramul Islam; Mahfuzar Rahman
Journal:  J Epidemiol Glob Health       Date:  2019-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.